Sirnaomics
Sirnaomics, founded in 2007 in Gaithersburg, Maryland, specializes in RNA therapeutics for diverse medical conditions and operates in the U.S. and Greater China.
History
Founded in 2007 in Gaithersburg, Maryland, Sirnaomics has established itself as a significant player in the field of RNA therapeutics. Over the years, the company has broadened its operations to include both the U.S. and Greater China. In 2022, Sirnaomics celebrated its 15th anniversary with the opening of new US headquarters and laboratories in Germantown, Maryland, marking a substantial milestone in its corporate journey. The company has also achieved international recognition by being listed on the Main Board of the Hong Kong Stock Exchange (HKEX).
Services
Sirnaomics specializes in RNA therapeutics aimed at addressing medical conditions with significant unmet needs. The company's therapeutic focus spans various areas including cancers, skin conditions, fibrosis-related diseases, antiviral and cardiometabolic diseases, and medical aesthetics. By leveraging its proprietary delivery platforms, Sirnaomics seeks to offer innovative treatment solutions that can improve patient outcomes in these medically challenging areas.
Proprietary Delivery Platforms
Sirnaomics utilizes proprietary delivery platforms that enhance the efficacy and targeting of RNA-based therapeutics. The company employs a polypeptide nanoparticle (PNP) delivery platform specifically designed for mRNA vaccines and therapeutics. Additionally, Sirnaomics has developed a GalNAc delivery platform aimed at liver-targeting RNAi therapeutics. These advanced delivery systems are pivotal in ensuring that the therapeutics reach their intended targets effectively, thereby maximizing their clinical benefit.
Clinical Development Pipeline
Sirnaomics possesses a robust clinical development pipeline focused on the creation and testing of novel RNA-based drugs. This pipeline includes a range of innovative therapeutics designed to address various medical conditions. Through ongoing clinical trials and research, Sirnaomics aims to bring groundbreaking treatments to market, ensuring that its drug candidates meet rigorous safety and efficacy standards before becoming available for patient use.
